JHG vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JHG presents a stark contradiction between valuation and operational health, highlighted by a weak Piotroski F-Score of 3/9. While the company exhibits explosive YoY earnings growth (244.6%) and trades significantly below its Graham Number ($62.47) and Intrinsic Value ($154.29), the low F-Score suggests deteriorating fundamental trends. This, combined with a very bearish technical trend (10/100) and low insider sentiment, indicates that the market is pricing in risks not immediately apparent in the growth metrics. The stock is a classic 'deep value' candidate that requires caution due to declining operational quality.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
JHG vs JPM: Head-to-Head Comparison
This page compares Janus Henderson Group plc (JHG) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.